Necrotizing vasculitis in Greece: Clinical, immunological and immunogenetic aspects, a study of 66 patients

British Journal of Rheumatology

Volumn 36, Issue 10, 1997, Pages 1059-1066

  Boki, K A ^b   Dafni, U ^b   Karpouzas, G A ^b   Papasteriades, C ^b   Drosos, A A ^b   Moutsopoulos, H M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE

Author keywords

Immunogenetic associations; Necrotizing vasculitis; Outcome; Therapeutic approaches

Indexed keywords

CYCLOPHOSPHAMIDE; HEPATITIS B SURFACE ANTIGEN; HLA ANTIGEN; HLA DR1 ANTIGEN; HLA DR3 ANTIGEN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; CLINICAL IMMUNOLOGY; FEMALE; GASTROINTESTINAL TRACT; GREECE; HUMAN; IMMUNOGENETICS; INTRAVENOUS DRUG ADMINISTRATION; LUNG; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; NECROTIZING ARTERITIS; ORAL DRUG ADMINISTRATION; PERIPHERAL NERVOUS SYSTEM; POLYARTERITIS NODOSA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN MANIFESTATION; STATISTICAL ANALYSIS; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT; WEGENER GRANULOMATOSIS;

EID: 0030700923     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/36.10.1059     Document Type: Article

References (33)

1. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
2. Abu-Shakra M, Smythe H, Lewtas J, Badley E, Weber D, Keystone E. Outcome of polyarteritis nodosa and Churg-Strauss syndrome. An analysis of twenty-five patients. Arthritis Rheum 1994;37:1798-803.
3. Fauci AS, Haynes BF, Katz P. The spectrum of vasculitis. Clinical, pathologic, immunologic, and therapeutic considerations. (NIH Conference). Ann Intern Med 1978;89:660-76.
4. Guillevin L, Le Thi Huong D, Godeau P, Jais P, Wechsler B. Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss angiitis. A study in 165 patients. Br J Rheumatol 1988;27:258-64.
5. Elkon KB, Sutherland DC, Rees AJ, Hughes GRV, Batchelor JR. HLA antigen frequencies in systemic vasculitis. Increase in HLA-DR2 in Wegener's granulomatosis. Arthritis Rheum 1983;26:102-5.
6. Papiha SS, Murty GE, Ad'Hia A, Mains BT, Venning M. Association of Wegener's granulomatosis with HLA antigens and other genetic markers. Ann Rheum Dis 1992;51:246-8.
7. Spencer SJW, Burns A, Gaskin G, Pusey CD, Rees AJ. HLA class II specificities in vasculitis with antibodies to neutrophil cytoplasmic antigens. Kidney Int 1992;41:1059-63.
8. Zhang L, Jayne DRW, Zhao MH, Lockwood CM, Oliveira DBG. Distribution of MHC class II alleles in primary systemic vasculitis. Kidney Int 1995;47:294-8.
9. Murty GE, Mains BT, Middleton D, Maxwell AP, Savage DA. HLA antigen frequencies and Wegener's granulomatosis. Clin Otolaryngol 1991;16:448-51.
10. Strimlan CV, Taswell HF, Kueppers F, DeRemee RA, McDonald TJ. HLA antigens of patients with Wegener's granulomatosis. Tissue Antigens 1978;11: 129-31.
11. Boki KA, Panayi GS, Vaughan RW, Drosos AA, Moutsopoulos HM, Lanchbury JS. HLA class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks. The HLA-DRb shared-epitope hypothesis accounts for the disease in only a minority of Greek patients. Arthritis Rheum 1992;35:749-55.
12. Roitberg-Tambur A, Friedmann A, Safirman C, Markitziu A, Ben-Chetrit E, Rubinow A et al. Molecular analysis of HLA class II genes in primary Sjögren's syndrome. A study of Israeli Jewish and Greek non-Jewish patients. Human Immunol 1993;36:235-42.
13. Reveille JD, Arnett FC, Olsen ML, Moulds JM, Papasteriades CA, Moutsopoulos HM. HLA-class II alleles and C4 null genes in Greeks with systemic lupus erythematosus. Tissue Antigens 1995;46:417-21.
14. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33: 1101-7.
15. Lightfoot RW Jr, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990;33:1088-93.
16. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33:1094-100.
17. Buyse J, Decorte R, Baens M, Cuppens H, Semana G, Emonds MP et al. Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot-blot hybridization. Tissue Antigens 1993;41:1-14.
18. SAS Institute Inc. SAS procedures guide, release 6.03 edn. Cary, NC: SAS Institute Inc., 1988.
19. StatXact. Cambridge, MA: CYTEL Software Corporation, 1991.
20. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76-85.
21. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD et al. Wegener's granulomatosis: An analysis of 158 patients. Ann Intern Med 1992;116:488-98.
22. Guillevin L, Lhote F, Amouroux J, Gherardi R, Callard P, Casassus P. Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: indications for the classification of vasculitides of the polyarteritis nodosa group. Br J Rheumatol 1996;35: 958-64.
23. Hadziyannis SJ, Giannoulis G, Hadziyannis E, Alexopoulou A, Dourakis SP, Trichopoulos D. Hepatitis C virus infection in Greece and its role in chronic liver disease and hepatocellular carcinoma. J Hepatol 1993;17(suppl. 3):S72-7.
24. Pachoula-Papasteriadis C, Ollier W, Cutbush S, Economidou J, Festenstein H. HLA antigen and haplo-type frequencies in Greeks. Tissue Antigens 1989;33:488-90.
25. Stegeman CA, Cohen Tervaert C, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CGM. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 1994;120:12-7.
26. Potempa J, Watorek W, Travis J. The inactivation of human plasma α1-proteinase inhibitor by proteinases from Staphylococcus aureus. J Biol Chem 1986;261: 14330-4.
27. Guillevin L, Lhote F, Cohen P, Sauvaget F, Jarrousse B, Lortholary O et al. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine 1995;74:238-53.
28. Reinhold-Keller E, Kekow J, Schnabel A, Schmitt WH, Heller M, Beigel A et al. Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis. Arthritis Rheum 1994;37:919-24.
29. Hoffman GS, Leavitt RY, Fleisher TA, Minor JR, Fauci AS. Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide. Am J Med 1990;89:403-10.
30. Drosos AA, Sakkas LI, Goussia A, Siamopoulos KC, Moutsopoulos HM. Pulse cyclophosphamide therapy in Wegener's granulomatosis: a pilot study. J Intern Med 1992;232:279-82.
31. Haubitz M, Frei U, Rother U, Brunkhorst R, Koch KM. Cyclophosphamide pulse therapy in Wegener's granulomatosis. Nephrol Dial Transplant 1991;6:531-5.
32. Falk RJ, Hogan TS, Jennette C. Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. Ann Intern Med 1990;113:656-63.
33. Vlachoyiannopoulos PG, Moutsopoulos HM. Rheumatoid arthritis in south-east Europe. Baillière's Clin Rheumatol 1992;6:221-33.